Sfoglia per Autore
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens.
2010-11-01 Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens
2010-11-01 Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf
The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion
2011-01-01 Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
HIV-1 R5+ /X4- tropic viruses can be inhibited in vitro as well as in vivo by maraviroc: a refined analysis of patients enrolled in the Phase IIb study A4001029
2011-01-01 CECCHERINI SILBERSTEIN, F; Surdo, M; Alteri, C; Puertas, M; Saccomandi, P; Artese, A; Balestra, E; Chapman, D; Lewis, M; Valdez, H; Clotet, B; Alcaro, S; Santoro, M; Svicher, V; Martinez Picado, J; Perno, Cf
Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score
2011-01-01 De Luca, A; Di Giambenedetto, S; Maserati, R; Gianotti, N; Narciso, P; Antinori, A; Di Perri, G; Prosperi, M; Baldanti, F; Micheli, V; Zazzi, M; Perno, Cf; Santoro, M
The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing
2011-01-01 Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, A; Antinori, A; Andreoni, M; Perno, Cf; Capobianchi, M; CECCHERINI SILBERSTEIN, F
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon
2011-04-05 Fokam, J; Salpini, R; Santoro, M; Cento, V; D'Arrigo, R; Gori, C; Perno, Cf; Colizzi, V; Nanfack, A; Gwom, L; Cappelli, G; Takou, D
Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy
2011-05-06 Véras, N; Santoro, M; Gray, R; Tatem, A; Presti, A; Olearo, F; Cappelli, G; Colizzi, V; Takou, D; Torimiro, J; Russo, G; Callegaro, A; Salpini, R; D'Arrigo, R; Perno, Cf; Goodenow, M; Ciccozzi, M; Salemi, M
Genetic diversity of HIV type 1 in Montenegro
2011-08-01 Ciccozzi, M; Vujošević, D; Lo Presti, A; Mugoša, B; Vratnica, Z; Lai, A; Laušević, D; Drašković, N; Marjanovic, A; Cella, E; Santoro, M; Alteri, C; Fabeni, L; Ciotti, M; Zehender, G
Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon
2011-08-03 Fokam, J; Salpini, R; Santoro, M; Cento, V; Perno, Cf; Colizzi, V; Ndumbe, P; Fokunang Ntungen, C; Ndiang Tetang, S; Nanfack, A; Takou Komego, D; Cappelli, G
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-01 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
2011-09-02 Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine
2011-12-09 Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V
Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon
2012-01-01 Ceccarelli, L; Salpini, R; Moudourou, S; Cento, V; Santoro, M; Fokam, J; Takou, D; Nanfack, A; Dori, L; Torimiro, J; Sarmati, L; Andreoni, M; Perno, Cf; Colizzi, V; Cappelli, G
Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy
2012-01-01 Santoro, M; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients
2012-08-03 Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Dori, L; Surdo, M; Balestra, E; Palamara, G; Girardi, E; Angarano, G; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
HIV-1 non-B subtypes in Italy: a growing trend
2012-10-01 Ciccozzi, M; Santoro, M; Giovanetti, M; Andrissi, L; Bertoli, A; Ciotti, M
The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing
2013-01-01 Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf
HIV-1 Genetic Variability and Clinical Implications
2013-01-01 Santoro, M; Perno, Cf
Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study
2013-01-01 Giuliani, M; Santoro, M; Lo Presti, A; Cella, E; Scognamiglio, P; Lai, A; Latini, A; Fabeni, L; Gori, C; Pinnetti, C; Girardi, E; Perno, Cf; Zehender, G; Ciccozzi, M
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-nov-2010 | Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. | Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf | Articolo su rivista | |
1-nov-2010 | Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens | Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf | Articolo su rivista | |
1-gen-2011 | The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion | Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Intervento a convegno | |
1-gen-2011 | HIV-1 R5+ /X4- tropic viruses can be inhibited in vitro as well as in vivo by maraviroc: a refined analysis of patients enrolled in the Phase IIb study A4001029 | CECCHERINI SILBERSTEIN, F; Surdo, M; Alteri, C; Puertas, M; Saccomandi, P; Artese, A; Balestra, E; Chapman, D; Lewis, M; Valdez, H; Clotet, B; Alcaro, S; Santoro, M; Svicher, V; Martinez Picado, J; Perno, Cf | Intervento a convegno | |
1-gen-2011 | Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score | De Luca, A; Di Giambenedetto, S; Maserati, R; Gianotti, N; Narciso, P; Antinori, A; Di Perri, G; Prosperi, M; Baldanti, F; Micheli, V; Zazzi, M; Perno, Cf; Santoro, M | Articolo su rivista | |
1-gen-2011 | The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing | Cento, V; Svicher, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Palamara, G; Latini, A; Rizzardini, G; Micheli, V; Buonomini, A; Antinori, A; Andreoni, M; Perno, Cf; Capobianchi, M; CECCHERINI SILBERSTEIN, F | Intervento a convegno | |
5-apr-2011 | Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon | Fokam, J; Salpini, R; Santoro, M; Cento, V; D'Arrigo, R; Gori, C; Perno, Cf; Colizzi, V; Nanfack, A; Gwom, L; Cappelli, G; Takou, D | Articolo su rivista | |
6-mag-2011 | Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy | Véras, N; Santoro, M; Gray, R; Tatem, A; Presti, A; Olearo, F; Cappelli, G; Colizzi, V; Takou, D; Torimiro, J; Russo, G; Callegaro, A; Salpini, R; D'Arrigo, R; Perno, Cf; Goodenow, M; Ciccozzi, M; Salemi, M | Articolo su rivista | |
1-ago-2011 | Genetic diversity of HIV type 1 in Montenegro | Ciccozzi, M; Vujošević, D; Lo Presti, A; Mugoša, B; Vratnica, Z; Lai, A; Laušević, D; Drašković, N; Marjanovic, A; Cella, E; Santoro, M; Alteri, C; Fabeni, L; Ciotti, M; Zehender, G | Articolo su rivista | |
3-ago-2011 | Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon | Fokam, J; Salpini, R; Santoro, M; Cento, V; Perno, Cf; Colizzi, V; Ndumbe, P; Fokunang Ntungen, C; Ndiang Tetang, S; Nanfack, A; Takou Komego, D; Cappelli, G | Articolo su rivista | |
1-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
2-set-2011 | 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing | Alteri, C; Santoro, M; Abbate, I; Rozera, G; Bruselles, A; Bartolini, B; Gori, C; Forbici, F; Orchi, N; Tozzi, V; Palamara, G; Antinori, A; Narciso, P; Girardi, E; Svicher, V; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
9-dic-2011 | Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine | Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V | Articolo su rivista | |
1-gen-2012 | Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon | Ceccarelli, L; Salpini, R; Moudourou, S; Cento, V; Santoro, M; Fokam, J; Takou, D; Nanfack, A; Dori, L; Torimiro, J; Sarmati, L; Andreoni, M; Perno, Cf; Colizzi, V; Cappelli, G | Articolo su rivista | |
1-gen-2012 | Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy | Santoro, M; Alteri, C; Ronga, L; Flandre, P; Fabeni, L; Mercurio, F; D'Arrigo, R; Gori, C; Palamara, G; Bertoli, A; Forbici, F; Salpini, R; Boumis, E; Tozzi, V; Visco Comandini, U; Zaccarelli, M; Van Houtte, M; Pattery, T; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
3-ago-2012 | The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients | Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Svicher, V; Bertoli, A; Dori, L; Surdo, M; Balestra, E; Palamara, G; Girardi, E; Angarano, G; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
1-ott-2012 | HIV-1 non-B subtypes in Italy: a growing trend | Ciccozzi, M; Santoro, M; Giovanetti, M; Andrissi, L; Bertoli, A; Ciotti, M | Articolo su rivista | |
1-gen-2013 | The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing | Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; CECCHERINI SILBERSTEIN, F; Capobianchi, M; Perno, Cf | Articolo su rivista | |
1-gen-2013 | HIV-1 Genetic Variability and Clinical Implications | Santoro, M; Perno, Cf | Articolo su rivista | |
1-gen-2013 | Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study | Giuliani, M; Santoro, M; Lo Presti, A; Cella, E; Scognamiglio, P; Lai, A; Latini, A; Fabeni, L; Gori, C; Pinnetti, C; Girardi, E; Perno, Cf; Zehender, G; Ciccozzi, M | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile